Mammalian target of rapamycin at the crossroad between Alzheimer’s disease and diabetes

Nursing and Health Professions

• Alzheimer's Disease 100%
• Cognitive Defect 14%
• Comorbidity 14%
• Diseases 14%
• Dyslipidemia 14%
• Economic and Social Development 28%
• Glucose Intolerance 14%
• Glycemic Control 14%
• Health Condition 14%
• Hyperglycemia 14%
• Hyperinsulinemia 14%
• Inflammation 14%
• Insulin Resistance 14%
• Insulin Sensitizing Agent 14%
• Mammalian Target of Rapamycin 100%
• Maturity Onset Diabetes of the Young 42%
• Medicare 14%
• Metabolic Disorder 14%
• Nutrient Availability 14%
• Patient with Alzheimer's Disease 28%
• Rapamycin 14%
• Valerian 14%

Neuroscience

• Alzheimer's Disease 100%
• Cell Stress 12%
• Cognitive Decline 25%
• Cognitive Disorders 12%
• Comorbidity 12%
• Diabetes Mellitus 12%
• Dyslipidemia 12%
• Glucose 12%
• Hyperglycemia 12%
• Hyperinsulinemia 12%
• Insulin 25%
• Mammalian Target of Rapamycin 100%
• Metabolic Disorder 12%
• Older Adults 25%
• Sirolimus 12%
• Target of Rapamycin Signaling Pathway 12%
• Valerian 12%

Biochemistry, Genetics and Molecular Biology

• Cell Stress 14%
• Comorbidity 14%
• Dyslipidemia 14%
• Glucose 14%
• Glycemic Control 14%
• Homeostasis 14%
• Hyperglycemia 14%
• Insulin 14%
• Insulin Resistance 14%
• Life Extension 14%
• Maturity Onset Diabetes of the Young 42%
• Mechanistic Target of Rapamycin 100%
• Metabolic Disorder 14%
• Sensitization 14%
• Signal Transduction 14%